Study #PA18-1171
Minimal Residual Disease Assessment in Colorectal Cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identified and studied further to provide information about the cancer. Information gathered from this study may help researchers better understand if ctDNA found in the blood can predict whether colorectal cancer may come back or spread.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Colorectal Adenocarcinoma;Stage I Colorectal Cancer AJCC V8;Stage II Colorectal Cancer AJCC V8;Stage IIA Colorectal Cancer AJCC V8;Stage IIB Colorectal Cancer AJCC V8;Stage IIC Colorectal Cancer AJCC V8;Stage III Colorectal Cancer AJCC V8;Stage IIIA Colorectal Cancer AJCC V8;Stage IIIB Colorectal Cancer AJCC V8;Stage IIIC Colorectal Cancer AJCC V8;Stage IV Colorectal Cancer AJCC V6;Stage IVA Colorectal Cancer AJCC V8;Stage IVB Colorectal Cancer AJCC V8;Stage IVC Colorectal Cancer AJCC V8
Study phase:
Physician name:
Arvind Nageshwara Vijaya Dasari
Department:
Gastrointestinal Medical Oncology
For general questions about clinical trials:
1-866-967-2182
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.